Filtered By:
Specialty: Internal Medicine
Source: Annals of Internal Medicine

This page shows you your search results in order of date. This is page number 2.

Order by Relevance | Date

Total 404 results found since Jan 2013.

In ischemic stroke, EVT improved 90-d function more than usual care across admission SBP levels
Ann Intern Med. 2023 Aug 1. doi: 10.7326/J23-0055. Online ahead of print.ABSTRACTSamuels N, van de Graaf RA, Mulder MJHL, et al; HERMES Collaborators. Admission systolic blood pressure and effect of endovascular treatment in patients with ischaemic stroke: an individual patient data meta-analysis. Lancet Neurol. 2023;22:312-319. 36931806.PMID:37523700 | DOI:10.7326/J23-0055
Source: Annals of Internal Medicine - July 31, 2023 Category: Internal Medicine Authors: Maryam Bahreini Eddy Lang Source Type: research

In AF, the effects of DOACs vs. warfarin on death and stroke/systemic embolism vary by baseline CrCl level
Ann Intern Med. 2023 Aug 1. doi: 10.7326/J23-0054. Online ahead of print.ABSTRACTHarrington J, Carnicelli AP, Hua K, et al. Direct oral anticoagulants versus warfarin across the spectrum of kidney function: patient-level network meta-analyses from COMBINE AF. Circulation. 2023;147:1748-1757. 37042255.PMID:37523701 | DOI:10.7326/J23-0054
Source: Annals of Internal Medicine - July 31, 2023 Category: Internal Medicine Authors: Stephanie Carlin James Douketis Source Type: research

In ischemic stroke, EVT improved 90-d function more than usual care across admission SBP levels
Ann Intern Med. 2023 Aug 1. doi: 10.7326/J23-0055. Online ahead of print.ABSTRACTSamuels N, van de Graaf RA, Mulder MJHL, et al; HERMES Collaborators. Admission systolic blood pressure and effect of endovascular treatment in patients with ischaemic stroke: an individual patient data meta-analysis. Lancet Neurol. 2023;22:312-319. 36931806.PMID:37523700 | DOI:10.7326/J23-0055
Source: Annals of Internal Medicine - July 31, 2023 Category: Internal Medicine Authors: Maryam Bahreini Eddy Lang Source Type: research

Comparative Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Recurrent Gout Flares and Gout-Primary Emergency Department Visits and Hospitalizations : A General Population Cohort Study
CONCLUSION: Among patients with gout, SGLT2is may reduce recurrent flares and gout-primary ED visits and hospitalizations and may provide cardiovascular benefits.PRIMARY FUNDING SOURCE: National Institute of Arthritis and Musculoskeletal and Skin Diseases.PMID:37487215 | DOI:10.7326/M23-0724
Source: Annals of Internal Medicine - July 24, 2023 Category: Internal Medicine Authors: Natalie McCormick Chio Yokose Jie Wei Na Lu Deborah J Wexler J Antonio Avi ña-Zubieta Mary A De Vera Yuqing Zhang Hyon K Choi Source Type: research

In ischemic stroke, adding EVT to usual care at 6 to 24 h improved functional status at 90 d
Ann Intern Med. 2023 Jul 4. doi: 10.7326/J23-0050. Online ahead of print.ABSTRACTOlthuis SGH, Pirson FAV, Pinckaers FME, et al; MR CLEAN-LATE investigators. Endovascular treatment versus no endovascular treatment after 6-24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial. Lancet. 2023;401:1371-1380. 37003289.PMID:37399551 | DOI:10.7326/J23-0050
Source: Annals of Internal Medicine - July 3, 2023 Category: Internal Medicine Authors: Barnet Eskin Source Type: research

Dyslipidemia
Ann Intern Med. 2023 Jun 13. doi: 10.7326/AITC202306200. Online ahead of print.ABSTRACTDyslipidemia is an important risk factor for coronary artery disease and stroke. All persons with dyslipidemia should be advised to focus on lifestyle interventions, including regular aerobic exercise, a healthy diet, maintenance of a healthy weight, and abstinence from smoking. In addition to lifestyle interventions, lipid-lowering therapy should be considered for persons at moderate to high risk for atherosclerotic cardiovascular disease based on validated risk equations. Statin therapy is the first-line medical treatment for dyslipide...
Source: Annals of Internal Medicine - June 12, 2023 Category: Internal Medicine Authors: Marios Arvanitis Charles J Lowenstein Source Type: research